Neumora Therapeutics Q4 EPS $(0.71) Misses $(0.55) Estimate
Portfolio Pulse from Benzinga Newsdesk
Neumora Therapeutics reported a Q4 EPS loss of $0.71, missing the consensus estimate of $0.55 by 29.09%.
March 07, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neumora Therapeutics reported a larger than expected quarterly loss, missing analyst estimates.
Missing earnings estimates, especially by a significant margin such as 29.09%, typically leads to negative investor sentiment in the short term. This could result in a decrease in stock price as investors adjust their expectations based on the new earnings information.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100